Join
Live feed
·
PRReleasevia Quantisnow
Kineta Inc. logo

Kineta Announces Exclusivity and Right of First Offer Agreement for its VISTA blocking antibody with TuHURA Biosciences

ByQuantisnow·Wall Street's wire, on your screen.
KA· Kineta Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KA (Kineta Inc.) and more on Quantisnow.